Sign In
Buy QTRX
$3.22
-0.270 (-7.74%)
At Close: Jun 23, 2026
Aberdeen Group plc Trims Stock Holdings in Quanterix Corporation $QTRX
03:08am, Friday, 10'th Apr 2026
Aberdeen Group plc reduced its position in shares of Quanterix Corporation (NASDAQ: QTRX) by 81.6% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchang
Quanterix Corporation Announces Date of 2026 Annual Meeting
04:00pm, Friday, 27'th Mar 2026
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection (the “Company”), today announced that th
Analyzing Quanterix (NASDAQ:QTRX) & IM Cannabis (NASDAQ:IMCC)
02:14am, Thursday, 19'th Mar 2026
Quanterix (NASDAQ: QTRX - Get Free Report) and IM Cannabis (NASDAQ: IMCC - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies bas
Quanterix (NASDAQ:QTRX) vs. TREES (OTCMKTS:CANN) Head-To-Head Review
01:30am, Monday, 09'th Mar 2026
TREES (OTCMKTS:CANN - Get Free Report) and Quanterix (NASDAQ: QTRX - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based o
Quanterix Corporation (QTRX) Q4 2025 Earnings Call Transcript
04:07am, Tuesday, 03'rd Mar 2026
Quanterix Corporation (QTRX) Q4 2025 Earnings Call Transcript
Quanterix Corporation (QTRX) Reports Q4 Loss, Beats Revenue Estimates
06:11pm, Monday, 02'nd Mar 2026
Quanterix Corporation (QTRX) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.3 per share a year ago.
Quanterix Releases Financial Results for the Fourth Quarter and Full Year 2025
04:01pm, Monday, 02'nd Mar 2026
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, today announced financial results for the f
Lucent Diagnostics and Life Line Screening Partner to Bring Advanced Blood-Based Diagnostics to Communities Nationwide
08:33am, Monday, 02'nd Mar 2026
BILLERICA, Mass.--(BUSINESS WIRE)--Lucent Diagnostics, a brand of Quanterix Corporation (NASDAQ: QTRX), today announced a partnership with Life Line Screening (LLS), a national organization focused on
Quanterix to Participate in Upcoming Investor Conferences
08:33am, Thursday, 26'th Feb 2026
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that i
Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026
08:33am, Friday, 20'th Feb 2026
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that i
Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer's Blood Test
02:00pm, Wednesday, 04'th Feb 2026
QTRX submits a 510(k) to the FDA for its multi-analyte blood test aimed at evaluating cognitive symptoms for possible Alzheimer's disease.
Quanterix Announces FDA 510(k) Submission for a Multi-Analyte Algorithmic Blood Test for Alzheimer's Disease Detection
08:33am, Tuesday, 03'rd Feb 2026
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (Nasdaq: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced it has
Quanterix Announces Landmark JAMA Study Highlighting Prognostic Value of Multi-Analyte Approach to Blood-Based Alzheimer's Risk Profiling
08:33am, Wednesday, 21'st Jan 2026
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced public
Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:01pm, Friday, 16'th Jan 2026
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery
Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026
04:30pm, Thursday, 08'th Jan 2026
BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery
